Skip to main content

Jessica Hagen

By Jessica Hagen | 01:04 pm | May 12, 2023
The company saw its stock price drop upon release of its first-quarter earnings.
By Jessica Hagen | 10:59 am | May 12, 2023
Andy Molnar, CEO of the Digital Therapeutics Alliance, discusses the market for digital therapeutics after Pear Therapeutics declared bankruptcy.
By Jessica Hagen | 02:00 pm | May 11, 2023
Employers will have access to Teladoc's virtual primary care services through HealthJoy's care navigation platform.
By Jessica Hagen | 11:42 am | May 11, 2023
The company's ANNE One platform allows for wireless monitoring of neonates and infants' skin and body temperature, heart and respiratory rates, and more.
By Jessica Hagen | 02:47 pm | May 10, 2023
The company also released its Q1 2023 earnings, showing increased revenue of $311.1 million with a net loss of $63.2 million.
By Jessica Hagen | 12:15 pm | May 10, 2023
The feature monitors heart rhythms suggestive of atrial fibrillation through the Galaxy Watch.  
By Jessica Hagen | 11:33 am | May 09, 2023
Patients in Emory's behavioral health program will utilize NeuroFlow's platform to have access to psychotherapy content between scheduled visits.
By Jessica Hagen | 02:09 pm | May 08, 2023
This is the second round of layoffs in less than a year.
By Jessica Hagen | 02:19 pm | May 05, 2023
In a blog post, the virtual care provider blasts the insurer for paying it less than other providers in California and refusing to process 'every single' out-of-network claim.
By Jessica Hagen | 12:23 pm | May 05, 2023
Boehringer Ingelheim and Click Therapeutics initiate clinical trial on PDTx treatment for schizophrenia and Akili's EndeavorRx shows promise for adults with ADHD.